of nucleoside 1 (500 mg, 0.88 mmol) in DMF (10 mL) was added
dropwise, and the reaction was stirred for a further 60 min at
which point it was deemed complete by TLC. The reaction mixture
was diluted with ethyl acetate (300 mL), washed with H2O (2 ¥
450 mL), 5% NaHCO3 (2 ¥ 450 mL), and finally H2O (2 ¥ 450 mL).
The aqueous phases were back-extracted in portions with ethyl
acetate (300 mL in total). The combined organic phase was dried
(MgSO4), filtered, and the solvent removed in vacuo to yield the
crude product as a pale yellow foam (667 mg). The crude product
was purified by column chromatography on silica with 60–100%
ethyl acetate in petroleum ether, the relevant fractions combined
and the eluent removed in vacuo to yield a rotameric mixture
(~0.66 : 0.33 by 1H NMR) of nucleoside 2a as a pale yellow foam
(567 mg, 76%). dH (300 MHz, CDCl3, Me4Si) (subscript A = major
rotamer, subscript B = minor rotamer; integrals are shown only
for dominating rotamer) 9.83 (1H, br s, NHA), 9.43 (br s, NHB),
7.70–7.12 (17H, m, Ar), 7.59 (1H, s, 6-HA), 7.57 (s, 6-HB), 6.80–
6.76 (4H, m, Ar), 5.95 (1H, t, 3¢-OH), 5.50 (s, H-1¢B), 5.44 (1H, s,
H-1¢A), 5.16 (s, H-2¢B), 4.73 (1H, s, H-2¢A), 4.38 (1H, s, H-3¢), 4.26–
4.08 (5H, m, H-5¢, H-5¢, CH-Fmoc, CH2-Fmoc), 3.71 (6H, s, 2 ¥
OCH3), 3.61–3.45 (4H, m, CH2, H5¢, H-5¢), 1.97 (s, 5-MeB), 1.58
(3H, s, 5-MeA); dC (75 MHz, CDCl3) 168.0, 164.5, 158.6, 157.0,
150.7, 144.5, 144.4, 143.9, 143.7, 141.2, 135.5, 135.4, 135.3, 135.2,
134.6, 130.1, 130.0, 129.2, 128.1, 127.9, 127.8, 127.7, 127.1, 125.2,
119.9, 113.4, 113.2, 110.7, 88.7, 88.0, 87.1, 86.8, 86.7, 70.1, 69.1,
67.4, 67.3, 63.0, 59.2, 55.2, 51.6, 47.1, 46.9, 43.1, 42.9, 12.7, 12.6;
HR ESI MS m/z 873.3070 ([M + Na]+, C49H46N4O10Na+ calcd
873.3106).
22.7, 14.1, 12.5, 12.4; HR MALDI MS m/z 832.4475 ([M + Na]+,
C48H63N3O8Na+ calcd 832.4507).
(1R,3R,4R,7S)-7-[2-Cyanoethoxy(diisopropylamino)-
phosphinoxy]-1-(4,4¢-dimethoxytrityloxymethyl)-5-[N-(fluoren-9-
ylmethoxycarbonyl)glycyl]-3-(thymin-1-yl)-2-oxa-5-
azabicyclo[2.2.1]heptane (3a)
Nucleoside 2a (517 mg, 0.61 mmol) was co-evaporated
with anhydrous dichloroethane. Diisopropylammonium tetra-
zolide (209 mg, 1.22 mmol, 2 eq.) was added and the
solids dissolved in CH2Cl2 (7 mL). 2-Cyanoethyl-N,N,N¢,N¢-
tetraisopropylphosphane (388 mL, 1.22 mmol, 2.0 eq) was added
dropwise and the reaction mixture was stirred at room temperature
for 12 h. The reaction mixture was diluted with ethyl acetate
(2.5 mL), washed with NaHCO3 (20 mL), and the aqueous phase
was back-extracted with CH2Cl2 (3 ¥ 10 mL). The combined
organic phase was dried (Na2SO4), filtered, and the eluent removed
in vacuo, yielding a pale yellow foam (crude yield 866 mg).
The foam was dissolved in the minimal amount of ethyl acetate
(2 mL) and added dropwise to cold petroleum ether (200 mL,
◦
app. 0 C). The precipitating mixture was stirred for 10 min, the
resulting cream-coloured solid filtered off and dried under vacuum
overnight. The mother liquor was concentrated in vacuo, the
crystallization procedure repeated, and following TLC analysis,
the crystallization products were combined (601 mg, 94%). dP
(121.5 MHz, CDCl3) 150.0, 149.7, 149.4, 148.3; HR ESI MS m/z
1051.4390 ([M + H]+, C58H64N6O11P+ calcd 1051.4365).
(1R,3R,4R,7S)-7-(2-Cyanoethoxy(diisopropylamino)-
phosphinoxy)-1-(4,4¢-dimethoxytrityloxymethyl)-5-
(hexadecanoyl)-3-(thymin-1-yl)-2-oxa-5-azabicyclo[2.2.1]heptane
(3b)
(1R,3R,4R,7S)-1-(4,4¢-Dimethoxytrityloxymethyl)-5-
(hexadecanoyl)-7-hydroxy-3-(thymin-1-yl)-2-oxa-5-
azabicyclo[2.2.1]heptane (2b)
Nucleoside 1 (1.51 g, 2.64 mmol) was co-evaporated with anhy-
drous toluene (2 ¥ 2 mL) and subsequently dissolved in anhydrous
CH2Cl2 (25 mL). Anhydrous pyridine (1.0 mL, 12.4 mmol,
4.7 equiv.) was added, the solution was cooled to 0 ◦C, and
palmitoyl chloride (0.75 g, 2.73 mmol, 1.02 equiv.) was added
dropwise. The reaction mixture was stirred at 0 ◦C for 2 h,
whereupon it was diluted with CH2Cl2 (25 mL) and washed with
sat. aq. NaHCO3 (2 ¥ 25 mL). The organic phase was dried
(MgSO4) and concentrated to dryness under reduced pressure. The
residue was purified by silica gel column chromatography using
MeOH/pyridine/CH2Cl2 (4 : 1 : 95, v/v/v) as eluent to afford a
Nucleoside 2b (1.423 g, 1.76 mmol) and diisopropylammonium
tetrazolide (0.453 g, 2.65 mmol, 1.5 equiv.) were mixed and dis-
solved in anhydrous CH2Cl2 (25 mL). 2-Cyanoethyl-N,N,N¢,N¢-
tetraisopropylphosphane (1.060 g, 3.52 mmol, 2.0 equiv.) was
added dropwise and the resulting mixture was stirred at room
temperature for 12 h. It was diluted with CH2Cl2 (25 mL),
washed with sat. aq. NaHCO3 (2 ¥ 25 mL), dried (Na2SO4) and
concentrated under reduced pressure. The residue was purified
by silica gel column chromatography using toluene–EtOH/Et3N
(91 : 7 : 2, v/v/v) as eluent to afford the amidite 3b as off-
white foam (1.089 g, 61%). Rf 0.43 (EtOH–toluene 1 : 10); dP
(121.5 MHz, CDCl3) 149.8, 149.3, 148.8, 147.3; HR ESI MS m/z
1032.5501 ([M + Na]+, C57H80N5O9PNa+ calcd 1032.5586).
1
rotameric mixture (~0.45 : 0.55 by H NMR) of nucleoside 2b as
a white solid (1.45 g, 68%). Rf 0.52 (MeOH–CH2Cl2 8 : 92); dH
(300 MHz, CDCl3, Me4Si) (subscript A = major rotamer, subscript
B = minor rotamer; integrals are shown only for major rotamer)
9.86 (br s, NHB), 9.44 (1H, br s, NHA), 7.66 (1H, s, 6-HA), 7.60
(s, 6-HB), 7.49–7.20 (9H, m, Ar), 6.84 (4H, m, Ar), 5.53 (s, H-
1¢B), 5.44 (1H, s, H-1¢A), 5.20 (s, H-3¢B), 4.53 (1H, s, H-3¢A), 4.37
(1H, s, H-2¢A), 4.30 (s, H-2¢B), 3.78 (6H, s, 2 ¥ OCH3), 3.82–3.62
(4H, m, H-5¢, H-5¢), 2.50–2.37, 2.17–2.13 (2H, m, CH2), 1.61 (3H,
2 ¥ s, 5-MeA+B), 1.65–1.50 (2H, m, CH2), 1.24–1.22 (24H, m, CH2),
0.87 (3H, t, J = 6.4 Hz, Me); dC (75 MHz, CDCl3) 173.5, 173.2,
164.5, 164.2, 158.7, 158.6, 150.1, 149.7, 144.4, 144.3, 135.5, 135.3,
135.2, 134.7, 130.1, 130.1, 130.0, 128.1, 128.0, 127.1, 127.0, 113.3,
113.2, 110.5, 109.9, 88.7, 88.0, 86.9, 86.8, 86.7, 70.2, 68.9, 63.6,
59.1, 59.6, 55.2, 34.2, 33.9, 31.9, 29.7, 29.6, 29.5, 29.3, 25.0, 24.6,
Oligonucleotide synthesis and purification
The oligonucleotides were synthesised in the DMT-ON mode
on an automated DNA synthesizer using an ExpediteTM Nucleic
Acid Synthesis System model 8909 from Applied Biosystems.
Synthesis was carried out in 0.2–1.0 mmol scale using polystyrene
resin purchased from Glen Research. Phosphoramidites 3a–b were
dissolved in acetonitrile as a 0.05 M solution and coupled using
tetrazole as an activator. The coupling time was 15–20 min for
amidites 3a–b, while commercial DNA phosphoramidites were
subjected to 2 min coupling time. After completion of the coupling
steps, the cyanoethyl protecting groups were removed from the
250 | Org. Biomol. Chem., 2011, 9, 243–252
This journal is
The Royal Society of Chemistry 2011
©